Clinical Evaluation of Adjusted Doses of Darunavir/Ritonavir With Rifampicin in HIV-infected Volunteers
Clinical trial NCT03892161 · TERMINATED
Trial details
- NCT number
- NCT03892161
- Sponsor
- University of Cape Town
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-12
- Primary completion
- 2018-11-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.